According to the Zhitong Finance App, Jinhai Medical Technology (02225) announced interim results for the six months ended June 30, 2026. The Group's revenue was SGD 34.21 million, up 134.16% year on year; loss attributable to shareholders was SGD 4.362 million, a year-on-year narrowing of 57.46%; loss per share was 0.08 Singapore points.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.